Faculty of Medicine and Health Sciences, Centre of Genomics and Policy, McGill University, Montreal, QC, Canada.
Eur J Hum Genet. 2022 Oct;30(10):1132-1137. doi: 10.1038/s41431-022-01103-z. Epub 2022 Apr 28.
This paper summarizes the results of a 31-country qualitative study of expert perspectives on the regulation of international "direct-to-participant" (DTP) genomic research. We outline how the practice of directly recruiting participants for genomic studies online complicates ethics and regulatory considerations for the return of individual research results. As part of a larger project supported by the National Human Genome Research Institute, National Institutes of Health, we prepared and distributed to 31 global legal experts a questionnaire intended to ascertain opinions and perspectives on the way international DTP genomic research is likely to be regulated. We found significant disagreement across jurisdictions on the most favorable approach to managing such results, with some countries favoring return by default and others preferring to return only with the express consent of research participants. We conclude by outlining policy considerations that should guide researcher practices in this context. As international DTP genomic research evolves, jurists and ethicists should be attentive to the ways novel approaches to subject recruitment align with existing ethical and regulatory norms in research with human participants. This paper is a preliminary step toward documenting such alignment in the context of the return of individual research results.
本文总结了一项针对 31 个国家的专家观点的定性研究结果,该研究探讨了国际“直接面向参与者”(DTP)基因组研究的监管。我们概述了在线直接招募参与者进行基因组研究的做法如何使个人研究结果的回报在伦理和监管方面变得复杂。作为美国国立卫生研究院国家人类基因组研究所资助的一个更大项目的一部分,我们向 31 名全球法律专家准备并分发了一份问卷,旨在了解他们对国际 DTP 基因组研究可能受到监管的方式的意见和看法。我们发现,在管理这些结果的最佳方法上,不同司法管辖区之间存在很大分歧,一些国家倾向于默认回报,而另一些国家则倾向于仅在研究参与者明确同意的情况下回报。最后,我们概述了在这种情况下应指导研究人员实践的政策考虑因素。随着国际 DTP 基因组研究的发展,法学家和伦理学家应该关注新颖的招募方法与人类参与者研究中现有伦理和监管规范之间的一致性。本文是在个人研究结果回报的背景下记录这种一致性的初步步骤。